Premium
Early experience with the Micro Plug Set for preterm patent ductus arteriosus closure
Author(s) -
Heyden Caitlin M.,
ElSaid Howaida G.,
Moore John W.,
Guyon Peter W.,
Katheria Anup C.,
Ratnayaka Kanishka
Publication year - 2020
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.29298
Subject(s) - medicine , ductus arteriosus , occlusion , surgery
Objectives We intend to describe early experience using a new, commercially available Micro Plug Set for preterm neonate and infant transcatheter patent ductus arteriosus (PDA) occlusion. Background Transcatheter PDA occlusion in premature neonates and small infants is safe and effective. The procedure is early in its evolution. Methods Procedural and short‐term outcomes of preterm neonates and infants undergoing transcatheter PDA occlusion with a new, commercially available device were reviewed. Results Eight preterm neonates and infants born at median 27 weeks gestation (23–36 weeks) underwent transcatheter PDA device closure with the Micro Plug Set. The device is short (2.5 mm) with a range of diameters (3, 4, 5, 6 mm) and delivered through a microcatheter. Procedures were performed at median 41 days of age (12–88 days) and at 1690 g (760–3,310 g). Transvenous PDA device occlusion was performed with fluoroscopic and echocardiography guidance. All procedures were successful with complete PDA occlusion. There were no procedural or short‐term adverse events. Conclusions Preterm neonate and infant transcatheter PDA device closure with a new, commercially available short and microcatheter delivered device (Micro Plug Set) was safe and effective in a small, early series of patients.